DHCR24 and cataract: Triparanol is the most widely used (nonspecific) DHCR24 inhibitor (Muller et al, 2019); however, it was withdrawn from clinical application due to severe adverse side effects, such as nausea and vomiting, cataracts, and skin disorders (Kirby, 1967).